Sign in Create account

Mukka Proteins Limited

Fast Moving Consumer Goods · Food Products

NSE: MUKKA BSE: 544135
₹25.98
▼ -0.35 (-1.33%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
36/100
Weak
Valuation
93/100
Undervalued
Momentum
31/100
Neutral

QVM read Cheap on its own multiples Quality Weak, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹779 Cr
PE (TTM)
12.7
Industry median 30.0 (70 companies)
Price to Book
1.5
PEG (TTM)
0.3
Institutions holding %
Data unavailable.
Piotroski Score
2
Relative return vs Nifty50, qtr %
12.7
Relative return vs Sector, qtr %
19.4
Free Cash Flow
₹-232 Cr
as of March 31, 2026
Industry median ₹-1 Cr (116 companies)
EPS Growth (YoY)
1550.00%
as of June 30, 2026
Industry median 1.00% (86 companies)
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
71.52%
as of June 30, 2026
Industry median 10.71% (86 companies)
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
198.88%
as of June 30, 2026
Industry median 9.85% (80 companies)
Current Ratio
1.23
as of March 31, 2026
Industry median 2.22 (115 companies)
Debt to Equity
1.45
as of March 31, 2026
Industry median 0.24 (95 companies)
Interest Coverage
2.53
as of June 30, 2026
Industry median 4.86 (88 companies)
Net Margin
4.78%
as of June 30, 2026
Industry median 3.59% (83 companies)
Operating Margin (EBIT)
10.39%
as of June 30, 2026
Industry median 6.55% (85 companies)
Operating Margin (TTM)
9.17%
as of June 30, 2026
Industry median 6.00% (90 companies)
Return on Assets
3.52%
as of March 31, 2026
Industry median 3.76% (89 companies)
Return on Capital Employed
22.14%
as of March 31, 2026
Industry median 13.81% (88 companies)
Return on Equity
10.80%
as of March 31, 2026
Industry median 7.67% (89 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 7 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 2)
  • No Debt to equity is below 0.5 (1.45)
  • No Return on equity is 15% or more (10.8%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

2 of 2 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median

Value and momentum

2 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-1.3%
Low 25.6600 · High 26.8800
1W return
-4.1%
Low 25.6600 · High 27.7500
1M return
4.7%
Low 24.6100 · High 33.2900
52W return
-2.9%
Low 18.2700 · High 33.2900
Lifetime High ₹54.2200 (July 16, 2024)
Lifetime Low ₹18.4900 (March 30, 2026)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish2
Bearish4
5D
26.7
10D
27.3
20D
27.6
50D
26.7
100D
25.5
200D
23.9

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
44.6%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

26.17
Pivot
First resistance26.69
Second resistance27.39
Third resistance27.91
First support25.47
Second support24.95
Third support24.25
Day RSI42.6
Day MFI60.5
Day MACD-0.06
Day MACD signal0.46

Beta

1M0.99
3M0.72
1Y1.08
3Y0.99

Price change analysis

↑ 4.7%
Over 1 Month
LowHigh
24.6133.29
↑ 7.7%
Over 3 Months
LowHigh
21.5033.29
↑ 27.6%
Over 6 Months
LowHigh
19.6833.29
↓ -2.9%
Over 1 Year
LowHigh
18.2733.29
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 12.7 (own history: 11.6–27.0)
Buy Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹406 Cr
Net profit (June 30, 2026)
₹19 Cr
Basic EPS (June 30, 2026)
₹0.6600

Ranks #29 of 96 in Food Products by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter73.33%
  • FII/FPI1.73%

Largest holders

NameCategoryShares %Shares
MOHAMMED HARIS KPromoter30.2300%90686800
K MOHAMMED ALTHAFPromoter16.1300%48400400
K MOHAMMAD ARIFPromoter16.1300%48400400
KALANDAN ABDUL RAZAKPromoter7.3300%22000000
UMAIYYA BANUPromoter3.5000%10511200

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 73.33% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings increased from 1.70% to 1.73% in Jun 2026 qtr

Historical mutual fund holding

All shareholding details →

Deals (Bulk & Block)

All 3 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
15 Jul 2024 GRAVITON RESEARCH CAPITAL LLP Bulk Sell 2,460,805 43.0900 NSE
11 Mar 2024 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Sell 1,560,185 41.5200 NSE
7 Mar 2024 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Buy 4,000,000 39.1300 NSE

All bulk and block deals →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
12 Aug 2026 Financial Results/Other business matters Yes
12 Jun 2026 Fund Raising/Other business matters —
15 May 2026 Financial Results/Fund Raising/Other business matters Yes
12 Feb 2026 Financial Results/Other business matters Yes
10 Feb 2026 Financial Results/Other business matters Yes

Corporate Announcements

All 247 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 Company Update Mukka Proteins Ltd - 544135 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
30 Sep 2026 Acquisition Mukka Proteins Limited has informed the Exchange about update on Acquisition
25 Sep 2026 Trading Window Mukka Proteins Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
25 Sep 2026 Insider Trading / SAST Mukka Proteins Ltd - 544135 - Closure of Trading Window
24 Sep 2026 Analysts/Institutional Investor Meet/Con. Call Updates Mukka Proteins Limited has informed the Exchange about Schedule of Analyst/institutional Investor Meeting.
24 Sep 2026 Analysts/Institutional Investor Meet/Con. Call Updates Mukka Proteins Limited has informed the Exchange about Schedule of meet on Monday, 28th September 2026.
22 Sep 2026 Analysts/Institutional Investor Meet/Con. Call Updates Mukka Proteins Limited has informed the Exchange about Schedule of meet
12 Sep 2026 AGM/EGM Mukka Proteins Ltd - 544135 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
12 Sep 2026 Company Update Mukka Proteins Ltd - 544135 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
12 Sep 2026 Analysts/Institutional Investor Meet/Con. Call Updates Mukka Proteins Limited has informed the Exchange about Schedule of Investor meet to be held on 17th September 2026

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong revenue growth YoY (198.9%)

Weaknesses

  • Thin net profit margin (4.8%)
  • High financial leverage (Debt/Equity 1.45)

Opportunities

  • PEG below 1 (0.26) -- earnings growth outpacing its own valuation
  • PE below 15 (12.7) relative to a typical growth business

Threats

Data unavailable.

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Mukka Proteins Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.